VSR Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$658K Sell
7,883
-18,110
-70% -$1.61M 0.11% 224
2016
Q1
$2.39M Buy
25,993
+4,136
+19% +$373K 0.25% 110
2015
Q4
$2.21M Sell
21,857
-510
-2% -$53.1K 0.24% 105
2015
Q3
$2.2M Buy
22,367
+1,341
+6% +$149K 0.25% 100
2015
Q2
$2.46M Buy
21,026
+12,052
+134% +$1.32M 0.26% 99
2015
Q1
$881K Buy
8,974
+815
+10% +$82.8K 0.09% 241
2014
Q4
$769K Buy
8,159
+18
+0.2% +$1.86K 0.09% 253
2014
Q3
$867K Buy
8,141
+589
+8% +$57.7K 0.1% 219
2014
Q2
$626K Buy
7,552
+1,640
+28% +$128K 0.08% 285
2014
Q1
$419K Sell
5,912
-136
-2% -$10.7K 0.06% 360
2013
Q4
$454K Buy
6,048
+745
+14% +$51.9K 0.07% 334
2013
Q3
$333K Buy
+5,303
New +$317K 0.06% 361

Other funds holding GILD

VSR Financial Services's GILD Position: Q2 2016 in Review

VSR Financial Services reduced its Gilead Sciences (GILD) stake by 70% in Q2 2016, selling an estimated $1.61M and leaving 7,883 shares worth $658K. The position accounts for 0.11% of the portfolio, ranked #224.

VSR Financial Services first reported a position in GILD in Q3 2013 and has held it in 12 quarters since. The position peaked at $2.46M in Q2 2015. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • VSR Financial Services held 7,883 shares of Gilead Sciences worth $658K as of Q2 2016.
  • VSR Financial Services sold 18,110 Gilead Sciences shares in Q2 2016, an estimated $1.61M.
  • Gilead Sciences made up 0.11% of VSR Financial Services's portfolio in Q2 2016, its #224 holding.
  • VSR Financial Services first reported a position in Gilead Sciences in Q3 2013 and has held it in 12 quarters since.
  • VSR Financial Services's Gilead Sciences position peaked at $2.46M in Q2 2015.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on VSR Financial Services's 13F filing for Q2 2016, filed 11 Aug 2016.